An immunocapture-LC-MS-based assay for serum SPINK1 allows simultaneous quantification and detection of SPINK1 variants

TATI as a biomarker

(2014) Outi Itkonen et al.   CLINICA CHIMICA ACTA

Frequency ofSPINK1 N34S mutation in acute and recurrent acute pancreatitis

(2014) Praveer Rai et al.   Journal of Hepato-Biliary-Pancreatic Sciences

PRSS1andSPINK1mutations in idiopathic chronic and recurrent acute pancreatitis

(2014) Mario Pelaez-Luna   WORLD JOURNAL OF GASTROENTEROLOGY

Absolute quantification of NAD(P)H:quinone oxidoreductase 1 in human tumor cell lines and tissues by liquid chromatography–mass spectrometry/mass spectrometry using both isotopic and non-isotopic internal standards

(2013) Zhiyuan Tang et al.   ANALYTICA CHIMICA ACTA

Quantitative Insulin Analysis Using Liquid Chromatography-Tandem Mass Spectrometry in a High-Throughput Clinical Laboratory

(2013) Z. Chen et al.   CLINICAL CHEMISTRY

Validation and comparison of tumor-associated trypsin inhibitor (TATI) immunoassays

(2012) Elisabete Janeiro et al.   CLINICA CHIMICA ACTA

Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus

(2012) Peter A Banks et al.   GUT

Mutant proteins as cancer-specific biomarkers

(2011) Q. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The SPINK1 N34S variant is associated with acute pancreatitis

(2009) Derek A. OʼReilly et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Pathways to Injury in Chronic Pancreatitis: Decoding the Role of the High-Risk SPINK1 N34S Haplotype Using Meta-Analysis

(2008) Elie Aoun et al.   PLoS One